Cutaneous reactions following COVID-19 vaccination: a review of the current literature

F Martora, T Battista, C Marasca, L Genco… - Clinical, Cosmetic …, 2022 - Taylor & Francis
The outbreak of coronavirus disease 2019 (COVID-19) represented a new worldwide
challenge, strongly impacting on the global economy, overall health and lifestyle. Since …

[HTML][HTML] The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature

F Martora, T Battista, A Ruggiero, M Scalvenzi, A Villani… - Viruses, 2023 - mdpi.com
Background: Four vaccines have been authorized by the European Medicines Agency
(EMA): viral vector-based vaccines (AstraZeneca; AZD1222 and Johnson & Johnson; Ad26 …

[HTML][HTML] Pemphigus during the COVID-19 epidemic: infection risk, vaccine responses and management strategies

X Huang, X Liang, J Zhang, H Su, Y Chen - Journal of Clinical Medicine, 2022 - mdpi.com
Pemphigus is a rare autoimmune blistering disease, involving potentially life-threatening
conditions often requiring immunosuppression. Currently, the COVID-19 pandemic caused …

[HTML][HTML] Autoimmune bullous diseases during COVID-19 pandemic: 2022 update on rituximab and vaccine

A Pira, JLM Sinagra, F Moro, F Mariotti… - Frontiers in …, 2023 - frontiersin.org
Autoimmune bullous diseases (AIBDs) are a heterogeneous group of life-threatening
disorders associated with subepidermal or intraepidermal blistering. Skin barrier alterations …

[HTML][HTML] New onset pemphigus foliaceus following AstraZeneca COVID‐19 vaccination

M Almasi‐Nasrabadi, RS Ayyalaraju… - Journal of the …, 2022 - ncbi.nlm.nih.gov
Dear Editor, Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are a rare group of
immunobullous disorders that can lead to high morbidity and mortality. 1 Analogous to the …

New Onset and Exacerbation of Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Systematic Review

PC Wu, IH Huang, CY Wang, CC Chi - Vaccines, 2024 - mdpi.com
Background: Cases of autoimmune bullous dermatosis (AIBD) have been reported following
COVID-19 vaccination. Objective: We aimed to provide an overview of clinical …

[HTML][HTML] New onset of pemphigus foliaceus following BBIBP COVID‐19 vaccine

M Pourani, F Bidari‐Zerehpoosh, A Ayatollahi… - Dermatologic …, 2022 - ncbi.nlm.nih.gov
Dear Editor, A 75-year-old man was referred to our clinic with pruritic figurate wheals and
cutaneous blisters along with crusted erosions on his chest, abdomen, and back appearing …

Pemphigus vulgaris after the second dose of COVID-19 vaccination: a case report

N Khalayli, A Omar, M Kudsi - Journal of Medical Case Reports, 2023 - Springer
Background As many people worldwide have been vaccinated, more triggered autoimmune
bullous diseases have been noticed. We reported a case of new-onset pemphigus Vulgaris …

New-onset or flare-up of bullous pemphigoid associated with COVID-19 vaccines: a systematic review of case report and case series studies

A Ghanaatpisheh, M Safari, H Haghshenas… - Frontiers in …, 2024 - frontiersin.org
Background Numerous cutaneous manifestations have been associated with the
Coronavirus Disease 2019 (COVID-19) outbreak and vaccination, but new-onset bullous …

[HTML][HTML] The multifactorial complexities of autoimmune development in Pemphigus vulgaris: Critical evaluation of the role of environmental and lifestyle “exposome” …

OT Adebiyi, DF Galloway, MS Augustin… - Frontiers in …, 2023 - frontiersin.org
Pemphigus vulgaris (PV) is a potentially life-threatening blistering disorder characterized by
autoantibodies directed against cell-cell adhesion molecules that serves as an excellent …